I am Dr. Bilal Shaker, a computational biologist and research engineer specializing in artificial intelligence for drug discovery. My journey began in Pakistan, where I earned my M.Phil. in Bioinformatics from Quaid-I-Azam University. In 2019, I moved to South Korea for my Ph.D. at Chung-Ang University, developing machine learning tools to predict blood-brain-barrier permeability, including LightBBB and LogBB_Pred. I received the Best Research Graduate Award in 2023. I then joined Ewha Womans University as a Brain Pool Korea Fellow, applying AI to drug design and allosteric modulator development. Currently, I am an Alberta Innovates Postdoctoral Fellow at the University of Canada, focusing on machine learning for ADMET prediction in drug discovery. My work has produced over 1,200 citations, publications in leading journals, and a patent application for epilepsy treatment. I remain dedicated to accelerating drug development through computational innovation.
I am Dr. Bilal Shaker, a computational biologist and research engineer specializing in artificial intelligence for drug discovery. My journey began in Pakistan, where I earned my M.Phil. in Bioinformatics from Quaid-I-Azam University. In 2019, I moved to South Korea for my Ph.D. at Chung-Ang University, developing machine learning tools to predict blood-brain-barrier permeability, including LightBBB and LogBB_Pred. I received the Best Research Graduate Award in 2023. I then joined Ewha Womans University as a Brain Pool Korea Fellow, applying AI to drug design and allosteric modulator development. Currently, I am an Alberta Innovates Postdoctoral Fellow at the University of Canada, focusing on machine learning for ADMET prediction in drug discovery. My work has produced over 1,200 citations, publications in leading journals, and a patent application for epilepsy treatment. I remain dedicated to accelerating drug development through computational innovation.